We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$191M
AUM Growth
+$14.8M
Cap. Flow
+$4.27M
Cap. Flow %
2.23%
Top 10 Hldgs %
47.22%
Holding
271
New
28
Increased
29
Reduced
43
Closed
22

Top Buys

Rank Stock Value
1
FFIV icon
F5
FFIV
+$5.25M
2
UMPQ
Umpqua Holdings Corp
UMPQ
+$4.89M
3
ORCL icon
Oracle
ORCL
+$2.77M
4
FSLR icon
First Solar
FSLR
+$2.04M
5
GILD icon
Gilead Sciences
GILD
+$467K

Sector Composition

Rank Sector Weight
1 Healthcare 26.37%
2 Technology 20.77%
3 Communication Services 15.92%
4 Industrials 11.33%
5 Financials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
201
DELISTED
Immunogen Inc
IMGN
$7K ﹤0.01%
1,000
AIG icon
202
American International
AIG
$40.2B
$6K ﹤0.01%
100
AFL icon
203
Aflac
AFL
$58.4B
$5K ﹤0.01%
124
DXC icon
204
DXC Technology
DXC
$1.79B
$5K ﹤0.01%
+77
New +$5.11K
JCI icon
205
Johnson Controls International
JCI
$84.6B
$5K ﹤0.01%
125
LITE icon
206
Lumentum
LITE
$80.3B
$5K ﹤0.01%
+80
New +$4.29K
MET icon
207
MetLife
MET
$61.3B
$5K ﹤0.01%
108
ULBI icon
208
Ultralife
ULBI
$108M
$5K ﹤0.01%
700
COP icon
209
ConocoPhillips
COP
$157B
$4K ﹤0.01%
100
-92
-48% -$4.29K
MZTI
210
The Marzetti Company
MZTI
$3.13B
$4K ﹤0.01%
30
MS.PRA icon
211
Morgan Stanley Series A Preferred Stock
MS.PRA
$755M
$4K ﹤0.01%
181
PSX icon
212
Phillips 66
PSX
$97.4B
$4K ﹤0.01%
+50
New +$3.92K
VIAV icon
213
Viavi Solutions
VIAV
$9.02B
$4K ﹤0.01%
+400
New +$4.31K
STD.PRB
214
DELISTED
SANTANDER FIN PREF SA UNIPERSONAL FTLG RT NON CUM SER 6 GUAR
STD.PRB
$4K ﹤0.01%
165
EFA icon
215
iShares MSCI EAFE ETF
EFA
$79.6B
$3K ﹤0.01%
40
-40
-50% -$2.59K
FTV icon
216
Fortive
FTV
$18B
$3K ﹤0.01%
68
-165
-71% -$6.49K
TRST
217
Trustco Bank Corp NY
TRST
$973M
$3K ﹤0.01%
71
TXN icon
218
Texas Instruments
TXN
$236B
$3K ﹤0.01%
40
-328
-89% -$26.3K
USB.PRH icon
219
US Bancorp Series B Preferred Stock
USB.PRH
$730M
$3K ﹤0.01%
115
VIVO
220
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
200
APA icon
221
APA Corp
APA
$14.9B
$2K ﹤0.01%
37
PBW icon
222
Invesco WilderHill Clean Energy ETF
PBW
$387M
$2K ﹤0.01%
100
PER
223
DELISTED
PEROT SYSTEMS CORP
PER
$2K ﹤0.01%
650
HYGS
224
DELISTED
Hydrogenics Corp
HYGS
$2K ﹤0.01%
233
BBD icon
225
Banco Bradesco
BBD
$34.4B
$1K ﹤0.01%
16
-1
-6% -$5

Similar funds

Prentiss Smith & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Prentiss Smith & Co held 271 positions worth $191M, up 8.4% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Prentiss Smith & Co's Q2 2017 filing shows 28 new, 29 increased, 43 reduced and 22 closed positions. Its largest new stake was Gilead Sciences: 7,018 shares worth $497K. The largest sale was Magna International, an estimated $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Prentiss Smith & Co's largest Q2 2017 buy was Gilead Sciences: 7,018 shares worth $497K.
  • Prentiss Smith & Co added most to F5 in Q2 2017, an estimated $5.25M increase.
  • Prentiss Smith & Co's biggest Q2 2017 reduction was Whole Foods Market Inc, cutting an estimated $3.12M.
  • Prentiss Smith & Co fully exited Magna International in Q2 2017, selling an estimated $7.44M.
  • Prentiss Smith & Co's ten largest holdings make up 47% of its $191M portfolio in Q2 2017.
  • Prentiss Smith & Co opened 28 new positions and closed 22 in Q2 2017.
  • Prentiss Smith & Co's portfolio value rose 8.4% quarter-over-quarter to $191M.

Based on Prentiss Smith & Co's 13F filing for Q2 2017, filed 10 Jul 2017.